← Open Payments lookup

LENETTE BALTAZAR: Open Payments

NPI 1851028245 · WAUKEGAN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,214 in 35 payments from 10 companies in 2025. Trend: 2023 $707 · 2024 $1,581 · 2025 $1,214

Food & beverage: $1,214
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.8$327
Otsuka America Pharmaceutical, Inc.10$309
E.R. Squibb & Sons, L.L.C.1$136
Lundbeck LLC5$117
ViiV Healthcare Company1$110
Janssen Pharmaceuticals, Inc3$56
Otsuka Pharmaceutical Development & Commercialization, Inc.2$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$45
Luye Pharma (USA) Ltd.2$42
Alkermes, Inc.1$27

Products named: UZEDY, REXULTI, ABILIFY ASIMTUFII, COBENFY, APRETUDE, INVEGA SUSTENNA, CAPLYTA, ERZOFRI EXTENDED-RELEASE.

Industry payments across IL — which companies pay providers there.